Item 5.07Item 5.07 - Submission of Matters to Vote
Item 5.07
Submission of Matters to a Vote of Security Holders
On July 22, 2026, McKesson Corporation (“Company”) held its Annual Meeting of Shareholders. Shown below are the final vote results on each of the items submitted to a vote and described in the Company’s definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 12, 2026.
Item 1
. Each of the following individuals nominated by the Board of Directors was elected to serve as a director, having received the following votes:
1
Director Nominee Votes For Votes Against Abstentions Broker Non-Votes
───────────────────────────────────────────────────────────────────────────────────────────────────────────────
Dominic J. Caruso 93,233,995 1,284,036 182,720 10,458,484
Lynne M. Doughtie 94,126,115 392,742 181,894 10,458,484
W. Roy Dunbar 92,974,900 1,474,974 250,877 10,458,484
Deborah Dunsire, M.D. 94,179,181 369,566 152,004 10,458,484
Julie L. Gerberding, M.D., M.P.H. 94,024,412 516,590 159,749 10,458,484
James H. Hinton 94,097,106 408,275 195,370 10,458,484
Bradley E. Lerman 92,956,921 1,557,363 186,467 10,458,484
Maria N. Martinez 88,547,303 5,963,501 189,947 10,458,484
Kevin M. Ozan 91,836,243 2,675,298 189,210 10,458,484
Brian S. Tyler 86,826,318 7,758,777 115,656 10,458,484
Kathleen Wilson-Thompson 94,095,670 434,360 170,721 10,458,484
Item 2
. The appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2027 was ratified, having received the following votes:
2
Votes For Votes Against Abstentions Broker Non-Votes
────────────────────────────────────────────────────────────────────────
95,066,170 9,872,183 220,882 0
Item 3
. The proposal to approve, on an advisory basis, the compensation of the Company’s named executive officers was approved, having received the following votes:
3
Votes For Votes Against Abstentions Broker Non-Votes
────────────────────────────────────────────────────────────────────────
86,580,776 7,732,776 387,199 10,458,484
1 A nominee will be elected as a director if he or she receives a majority of votes cast (that is, the number of votes cast “for” a director nominee must exceed the number of votes cast “against” that nominee). Abstentions and broker non-votes will not count as votes cast and will have no effect on the outcome of the matter.
2 Approval requires the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the proposal. Shares represented by abstentions will have the effect of a vote against this proposal. Brokers can cast discretionary votes on this proposal.
3 Approval requires the affirmative vote of a majority of the voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the proposal. Shares represented by abstentions will have the effect of a vote against this proposal. Broker non-votes with respect to this proposal will have no effect on the outcome of the matter.
